Nuclear Medicine Our Product Portfolio

Discover our portfolio of radiodiagnostics and therapeutic — designed to support better outcomes for patients worldwide.

01
Supporting the diagnosis and management of cardiovascular diseases.
02
Advancing nuclear medicine solutions for endocrine and metabolic disorders.
03
Supporting the evaluation of gastrointestinal function and disease through precision imaging.
04
Providing nuclear medicine solutions for blood disorders and related cancers.
05
Helping detect and monitor infection and inflammatory disease with precision imaging.
06
Supporting liver and spleen imaging with specialised nuclear medicine solutions.
07
Advancing lymphatic imaging solutions for disease staging and treatment planning.
08
Enhancing the detection and monitoring of bone and joint conditions.
09
Supporting renal imaging and kidney function assessment through nuclear medicine.
10
Advancing brain imaging solutions for neurological disorders and diseases.
11
Delivering precision nuclear medicine solutions for cancer diagnosis and treatment.
12
Supporting lung imaging and respiratory assessment with advanced nuclear medicine solutions.
13
Providing reliable radionuclide generator technologies for diagnostic isotope production.
14
Supporting the diagnosis and treatment of rare diseases through specialised nuclear medicine solutions.
15
Supporting the evaluation of inflammatory and autoimmune musculoskeletal disorders.
16
Providing nuclear medicine solutions for the diagnosis and management of urological conditions.

Selected

Disease Area

Cardiology
Endocrinology
Gastroenterology
Hematology
Infectious Diseases
Liver & Spleen
Lymphology
Musculoskeletal
Nephrology
Neurology
Oncology
Pulmonology
Radionuclide Generators
Rare Diseases
Rheumatology
Urology

Product Type

Therapeutic
PET
SPECT
Active Ingredient
Medical Device

Manufacturing Site

Maryland Heights
Petten
Saclay
Gebze

Market

All products A-Z

Dopacis®

Fluorodopa (18F) 90 MBq/mL solution for injection

Active ingredient

F18-fluorodopa

Disease area

Neurology, Oncology

Available in
, 

Dopacis® in Belgium

Product information
, 

Dopacis® in France

Product information
, 

Dopacis® in International

Product information
, 

Dopacis® in Italy

Product information
, 

Dopacis® in Luxembourg

Product information
, 

Dopacis® in Malta

Product information
, 

Dopacis® in Netherlands

Product information
, 

Dopacis® in Portugal

Product information
, 

Dopacis® in Slovenia

Product information

Dopacis® in Spain

Product information

Fludeoxyglucose (18F)-Curium

Fludeoxyglucose (18F)-Curium 185 MBq/mL solution for injection

Active ingredient

F18-fludesoxyglucose

Disease area

Cardiology, Infectious Diseases, Neurology, Oncology

Available in
, 

Fludeoxyglucose (18F)-Curium in Austria

Product information
, 

Fludeoxyglucose (18F)-Curium in Belgium

Product information
, 

Fludeoxyglucose (18F)-Curium in France

Product information
, 

Fludeoxyglucose (18F)-Curium in International

Product information
, 

Fludeoxyglucose (18F)-Curium in Italy

Product information
, 

Fludeoxyglucose (18F)-Curium in Luxembourg

Product information
, 

Fludeoxyglucose (18F)-Curium in Malta

Product information
, 

Fludeoxyglucose (18F)-Curium in Netherlands

Product information
, 

Fludeoxyglucose (18F)-Curium in Portugal

Product information
, 

Fludeoxyglucose (18F)-Curium in Slovenia

Product information

Fludeoxyglucose (18F)-Curium in Spain

Product information

Fluorocholine (18F)

Fluorocholine (18F) CIS bio international 225 MBq/mL solution for injection

Active ingredient

F18-fluorocholine

Disease area

Oncology

Available in
, 

Fluorocholine (18F) in Belgium

Product information
, 

Fluorocholine (18F) in France

Product information
, 

Fluorocholine (18F) in International

Product information
, 

Fluorocholine (18F) in Italy

Product information
, 

Fluorocholine (18F) in Luxembourg

Product information
, 

Fluorocholine (18F) in Malta

Product information
, 

Fluorocholine (18F) in Netherlands

Product information
, 

Fluorocholine (18F) in Portugal

Product information
, 

Fluorocholine (18F) in Slovenia

Product information

Fluorocholine (18F) in Spain

Product information

GalenVita

GalenVita 0.74 –3.70 GBq radionuclide generator

Active ingredient

Germanium (68Ge) chloride / gallium (68Ga) chloride

Disease area

Radionuclide Generators

Available in
, 

GalenVita in Austria

Product information
, 
, 

GalenVita in Bulgaria

Product information
, 

GalenVita in Croatia

Product information
, 

GalenVita in Cyprus

Product information
, 

GalenVita in Czech Republic

Product information
, 

GalenVita in Denmark

Product information
, 

GalenVita in Estonia

Product information
, 

GalenVita in Finland

Product information
, 

GalenVita in France

Product information
, 

GalenVita in Germany

Product information
, 

GalenVita in Greece

Product information
, 

GalenVita in Hungary

Product information
, 

GalenVita in Iceland

Product information
, 

GalenVita in Ireland

Product information
, 

GalenVita in Italy

Product information
, 

GalenVita in Latvia

Product information
, 

GalenVita in Liechestein

Product information
, 

GalenVita in Lithuania

Product information
, 

GalenVita in Luxembourg

Product information
, 

GalenVita in Malta

Product information
, 

GalenVita in Netherlands

Product information
, 

GalenVita in Norway

Product information
, 

GalenVita in Poland

Product information
, 

GalenVita in Portugal

Product information
, 

GalenVita in Romania

Product information
, 

GalenVita in Slovakia

Product information
, 

GalenVita in Slovenia

Product information
, 

GalenVita in Spain

Product information

GalenVita in Sweden

Product information

Pulmocis®

Human albumin as macroaggregates 2 mg, kit for radiopharmaceutical preparation

Active ingredient

macroaggregated human albumin (macrosalb)

Disease area

Pulmonology

Available in
, 

Pulmocis® in Austria

Product information
, 

Pulmocis® in Belgium

Product information
, 

Pulmocis® in Colombia

Product information
, 

Pulmocis® in Croatia

Product information
, 

Pulmocis® in Czech Republic

Product information
, 

Pulmocis® in Denmark

Product information
, 

Pulmocis® in Finland

Product information
, 

Pulmocis® in France

Product information
, 

Pulmocis® in Germany

Product information
, 

Pulmocis® in Greece

Product information
, 

Pulmocis® in International

Product information
, 

Pulmocis® in Ireland

Product information
, 

Pulmocis® in Italy

Product information
, 

Pulmocis® in Luxembourg

Product information
, 

Pulmocis® in Malta

Product information
, 

Pulmocis® in Netherlands

Product information
, 

Pulmocis® in Norway

Product information
, 

Pulmocis® in Portugal

Product information
, 

Pulmocis® in Slovakia

Product information
, 

Pulmocis® in Slovenia

Product information
, 

Pulmocis® in Spain

Product information
, 

Pulmocis® in Sweden

Product information

Pulmocis® in United Kingdom

Product information

Quadramet®

Quadramet, 1.3 GBq/mL solution for injection

Active ingredient

Sm153-lexidronam

Disease area

Oncology

Available in
, 

Quadramet® in Austria

Product information
, 

Quadramet® in Belgium

Product information
, 

Quadramet® in Bulgaria

Product information
, 

Quadramet® in Croatia

Product information
, 

Quadramet® in Cyprus

Product information
, 

Quadramet® in Czech Republic

Product information
, 

Quadramet® in Denmark

Product information
, 

Quadramet® in Estonia

Product information
, 

Quadramet® in Finland

Product information
, 

Quadramet® in France

Product information
, 

Quadramet® in Germany

Product information
, 

Quadramet® in Greece

Product information
, 

Quadramet® in Hungary

Product information
, 

Quadramet® in Iceland

Product information
, 

Quadramet® in International

Product information
, 

Quadramet® in Ireland

Product information
, 

Quadramet® in Italy

Product information
, 

Quadramet® in Latvia

Product information
, 

Quadramet® in Lithuania

Product information
, 

Quadramet® in Luxembourg

Product information
, 

Quadramet® in Malta

Product information
, 

Quadramet® in Mexico

Product information
, 

Quadramet® in Netherlands

Product information
, 

Quadramet® in Norway

Product information
, 

Quadramet® in Poland

Product information
, 

Quadramet® in Portugal

Product information
, 

Quadramet® in Romania

Product information
, 

Quadramet® in Slovakia

Product information
, 

Quadramet® in Slovenia

Product information
, 

Quadramet® in Spain

Product information
, 

Quadramet® in Sweden

Product information

Quadramet® in United Kingdom

Product information

Stamicis®

Stamicis 1 mg kit for radiopharmaceutical preparation

Active ingredient

[tetrakis (2-methoxyisobutyl isonitrile) copper (I)] tetrafluoroborate (sestamibi)

Disease area

Cardiology

Available in
, 

Stamicis® in Australia

Product information
, 

Stamicis® in Austria

Product information
, 

Stamicis® in Belgium

Product information
, 

Stamicis® in Colombia

Product information
, 

Stamicis® in Czech Republic

Product information
, 

Stamicis® in Denmark

Product information
, 

Stamicis® in Finland

Product information
, 

Stamicis® in France

Product information
, 

Stamicis® in Germany

Product information
, 

Stamicis® in Greece

Product information
, 

Stamicis® in India

Product information
, 

Stamicis® in International

Product information
, 

Stamicis® in Ireland

Product information
, 

Stamicis® in Israel

Product information
, 

Stamicis® in Italy

Product information
, 

Stamicis® in Luxembourg

Product information
, 

Stamicis® in Netherlands

Product information
, 

Stamicis® in Norway

Product information
, 

Stamicis® in Peru

Product information
, 

Stamicis® in Portugal

Product information
, 

Stamicis® in Republic of Korea

Product information
, 

Stamicis® in Singapore

Product information
, 

Stamicis® in Slovakia

Product information
, 

Stamicis® in Slovenia

Product information
, 

Stamicis® in Spain

Product information
, 

Stamicis® in Sweden

Product information
, 

Stamicis® in Switzerland

Product information

Stamicis® in United Kingdom

Product information

Striascan™

Striascan 74 MBq/mL solution for injection

Active ingredient

I123-ioflupane

Disease area

Neurology

Available in
, 

Striascan™ in Austria

Product information
, 

Striascan™ in Belgium

Product information
, 

Striascan™ in Bulgaria

Product information
, 

Striascan™ in Croatia

Product information
, 

Striascan™ in Cyprus

Product information
, 

Striascan™ in Czech Republic

Product information
, 

Striascan™ in Denmark

Product information
, 

Striascan™ in Estonia

Product information
, 

Striascan™ in Finland

Product information
, 

Striascan™ in France

Product information
, 

Striascan™ in Germany

Product information
, 

Striascan™ in Greece

Product information
, 

Striascan™ in Hungary

Product information
, 

Striascan™ in Iceland

Product information
, 

Striascan™ in International

Product information
, 

Striascan™ in Ireland

Product information
, 

Striascan™ in Italy

Product information
, 

Striascan™ in Latvia

Product information
, 

Striascan™ in Lithuania

Product information
, 

Striascan™ in Luxembourg

Product information
, 

Striascan™ in Malta

Product information
, 

Striascan™ in Netherlands

Product information
, 

Striascan™ in Norway

Product information
, 

Striascan™ in Poland

Product information
, 

Striascan™ in Portugal

Product information
, 

Striascan™ in Romania

Product information
, 

Striascan™ in Slovakia

Product information
, 

Striascan™ in Slovenia

Product information
, 

Striascan™ in Spain

Product information
, 

Striascan™ in Sweden

Product information
, 

Striascan™ in Switzerland

Product information
, 

Striascan™ in Turkey

Product information

Striascan™ in United Kingdom

Product information

Technescan™ Sestamibi

Technescan Sestamibi 1 mg kit for radiopharmaceutical preparation

Active ingredient

[Tetrakis (2-methoxy-2-methylpropyl-1 isocyanide)copper(I)] tetrafluoroborate

Disease area

Cardiology, Endocrinology, Oncology

Available in
, 

Technescan™ Sestamibi in Austria

Product information
, 

Technescan™ Sestamibi in Belgium

Product information
, 

Technescan™ Sestamibi in Bulgaria

Product information
, 

Technescan™ Sestamibi in Cyprus

Product information
, 

Technescan™ Sestamibi in Czech Republic

Product information
, 

Technescan™ Sestamibi in Denmark

Product information
, 

Technescan™ Sestamibi in Estonia

Product information
, 

Technescan™ Sestamibi in Finland

Product information
, 

Technescan™ Sestamibi in France

Product information
, 

Technescan™ Sestamibi in Germany

Product information
, 

Technescan™ Sestamibi in Greece

Product information
, 

Technescan™ Sestamibi in Hungary

Product information
, 

Technescan™ Sestamibi in International

Product information
, 

Technescan™ Sestamibi in Ireland

Product information
, 

Technescan™ Sestamibi in Italy

Product information
, 

Technescan™ Sestamibi in Latvia

Product information
, 

Technescan™ Sestamibi in Lithuania

Product information
, 

Technescan™ Sestamibi in Luxembourg

Product information
, 

Technescan™ Sestamibi in Netherlands

Product information
, 

Technescan™ Sestamibi in Norway

Product information
, 

Technescan™ Sestamibi in Portugal

Product information
, 

Technescan™ Sestamibi in Romania

Product information
, 

Technescan™ Sestamibi in Slovakia

Product information
, 

Technescan™ Sestamibi in Slovenia

Product information
, 

Technescan™ Sestamibi in Spain

Product information
, 

Technescan™ Sestamibi in Sweden

Product information
, 

Technescan™ Sestamibi in Switzerland

Product information

Technescan™ Sestamibi in United Kingdom

Product information

Thallium 201TI

Thallium (201Tl) chloride CIS bio international 37 MBq/mL solution for injection (Tl-201-S-1)

Active ingredient

Tl201-chloride

Disease area

Cardiology, Endocrinology, Musculoskeletal, Oncology

Available in
, 

Thallium 201TI in Austria

Product information
, 

Thallium 201TI in Belgium

Product information
, 

Thallium 201TI in France

Product information
, 

Thallium 201TI in Greece

Product information
, 

Thallium 201TI in International

Product information
, 

Thallium 201TI in Luxembourg

Product information
, 

Thallium 201TI in Mexico

Product information
, 

Thallium 201TI in Netherlands

Product information
, 

Thallium 201TI in Portugal

Product information
, 

Thallium 201TI in South America

Product information
, 

Thallium 201TI in Spain

Product information

Thallium 201TI in Taiwan

Product information

Ultra Technekow™ FM

Ultra-Technekow FM 2.15-43.00 GBq radionuclide generator

Active ingredient

Sodium molybdate (Mo-99)/sodium pertechnetate (Tc-99m)

Disease area

Endocrinology, Radionuclide Generators

Available in
, 

Ultra Technekow™ FM in Austria

Product information
, 

Ultra Technekow™ FM in Belgium

Product information
, 

Ultra Technekow™ FM in Bosnia

Product information
, 

Ultra Technekow™ FM in Colombia

Product information
, 

Ultra Technekow™ FM in Costa Rica

Product information
, 

Ultra Technekow™ FM in Cyprus

Product information
, 

Ultra Technekow™ FM in Czech Republic

Product information
, 

Ultra Technekow™ FM in Denmark

Product information
, 

Ultra Technekow™ FM in Dominican Republic

Product information
, 

Ultra Technekow™ FM in Finland

Product information
, 

Ultra Technekow™ FM in France

Product information
, 

Ultra Technekow™ FM in Germany

Product information
, 

Ultra Technekow™ FM in Greece

Product information
, 

Ultra Technekow™ FM in Hong Kong

Product information
, 

Ultra Technekow™ FM in Hungary

Product information
, 

Ultra Technekow™ FM in India

Product information
, 

Ultra Technekow™ FM in Ireland

Product information
, 

Ultra Technekow™ FM in Italy

Product information
, 

Ultra Technekow™ FM in Luxembourg

Product information
, 

Ultra Technekow™ FM in Malaysia

Product information
, 

Ultra Technekow™ FM in Moldova

Product information
, 

Ultra Technekow™ FM in Netherlands

Product information
, 

Ultra Technekow™ FM in Norway

Product information
, 

Ultra Technekow™ FM in Peru

Product information
, 

Ultra Technekow™ FM in Poland

Product information
, 

Ultra Technekow™ FM in Portugal

Product information
, 

Ultra Technekow™ FM in Republic of Korea

Product information
, 

Ultra Technekow™ FM in Romania

Product information
, 

Ultra Technekow™ FM in Serbia

Product information
, 

Ultra Technekow™ FM in Singapore

Product information
, 

Ultra Technekow™ FM in Slovakia

Product information
, 

Ultra Technekow™ FM in Spain

Product information
, 

Ultra Technekow™ FM in Sweden

Product information
, 

Ultra Technekow™ FM in Switzerland

Product information
, 

Ultra Technekow™ FM in Turkey

Product information

Ultra Technekow™ FM in United Kingdom

Product information

Vasculocis®

Vasculocis 10 mg kit for radiopharmaceutical preparation

Active ingredient

human serum albumin

Disease area

Cardiology

Available in
, 
, 

Vasculocis® in Denmark

Product information
, 

Vasculocis® in Finland

Product information
, 

Vasculocis® in France

Product information
, 

Vasculocis® in International

Product information
, 

Vasculocis® in Luxembourg

Product information
, 

Vasculocis® in Netherlands

Product information

Vasculocis® in Sweden

Product information

Yttrium 90Y

Yttrium (90Y) citrate CIS bio international 150-370 MBq/mL suspension for intraarticular injection (YMM-1)

Active ingredient

Y90-citrate

Disease area

Rheumatology

Available in
, 

Yttrium 90Y in Belgium

Product information
, 

Yttrium 90Y in Czech Republic

Product information
, 

Yttrium 90Y in France

Product information
, 

Yttrium 90Y in Germany

Product information
, 

Yttrium 90Y in Hungary

Product information
, 

Yttrium 90Y in International

Product information
, 

Yttrium 90Y in Italy

Product information
, 

Yttrium 90Y in Luxembourg

Product information
, 

Yttrium 90Y in Netherlands

Product information
, 

Yttrium 90Y in Slovakia

Product information
, 

Yttrium 90Y in South America

Product information
, 

Yttrium 90Y in Spain

Product information

Yttrium 90Y in Switzerland

Product information